학술논문

Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)
Document Type
Article
Source
In: BJU International. (BJU International, 1 April 2017, 119(4):522-529)
Subject
Language
English
ISSN
1464410X
14644096